[go: up one dir, main page]

ES2575234A1 - Equipo de suministro de insulina no invasivo - Google Patents

Equipo de suministro de insulina no invasivo Download PDF

Info

Publication number
ES2575234A1
ES2575234A1 ES201531400A ES201531400A ES2575234A1 ES 2575234 A1 ES2575234 A1 ES 2575234A1 ES 201531400 A ES201531400 A ES 201531400A ES 201531400 A ES201531400 A ES 201531400A ES 2575234 A1 ES2575234 A1 ES 2575234A1
Authority
ES
Spain
Prior art keywords
invasive
insulin
translation
machine
equipment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201531400A
Other languages
English (en)
Other versions
ES2575234B1 (es
Inventor
Joaquín BUSTELO DE LA QUINTANA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DISPOSITIVOS NO INVASIVOS PARA DIAGNOSIS S L
DISPOSITIVOS NO INVASIVOS PARA DIAGNOSIS SL
Original Assignee
DISPOSITIVOS NO INVASIVOS PARA DIAGNOSIS S L
DISPOSITIVOS NO INVASIVOS PARA DIAGNOSIS SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DISPOSITIVOS NO INVASIVOS PARA DIAGNOSIS S L, DISPOSITIVOS NO INVASIVOS PARA DIAGNOSIS SL filed Critical DISPOSITIVOS NO INVASIVOS PARA DIAGNOSIS S L
Priority to ES201531400A priority Critical patent/ES2575234B1/es
Publication of ES2575234A1 publication Critical patent/ES2575234A1/es
Application granted granted Critical
Publication of ES2575234B1 publication Critical patent/ES2575234B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A61B5/6814—Head
    • A61B5/6815—Ear
    • A61B5/6817—Ear canal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Optics & Photonics (AREA)
  • Otolaryngology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

Equipo de suministro de insulina no invasivo El equipo de la invención permite medir y calcular en tiempo real de forma no invasiva un perfil glucémico real a partir del cual aplicar igualmente de forma no invasiva, aportaciones de insulina, debidamente dosificadas y en los momentos concretos en los que la misma es necesaria, lo que redunda en una mejora sustancial en la calidad de vida para el diabético, no sufriendo ningún tipo de proceso invasivo. Para ello, el equipo está constituido a partir de un sensor del nivel de glucemia (1) con un espectrofotómetro (5), una muñequera (2) con un display (16) para visualización de dichos niveles, y un cinturón (3) asociado a una bomba de insulina no invasiva (20), basada en la iontoforesis, que aplica la insulina por medio de dos electrodos (21) y (22) de forma automática e indolora.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8

Claims (1)

  1. imagen1
    imagen2
ES201531400A 2015-09-30 2015-09-30 Equipo de suministro de insulina no invasivo Expired - Fee Related ES2575234B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201531400A ES2575234B1 (es) 2015-09-30 2015-09-30 Equipo de suministro de insulina no invasivo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201531400A ES2575234B1 (es) 2015-09-30 2015-09-30 Equipo de suministro de insulina no invasivo

Publications (2)

Publication Number Publication Date
ES2575234A1 true ES2575234A1 (es) 2016-06-27
ES2575234B1 ES2575234B1 (es) 2017-04-05

Family

ID=56134735

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201531400A Expired - Fee Related ES2575234B1 (es) 2015-09-30 2015-09-30 Equipo de suministro de insulina no invasivo

Country Status (1)

Country Link
ES (1) ES2575234B1 (es)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179951A (en) * 1990-04-19 1993-01-19 Inomet, Inc. Blood constituent measurement
US20030144581A1 (en) * 1999-02-12 2003-07-31 Cygnus, Inc. Devices and methods for frequent measurement of an analyte present in a biological system

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179951A (en) * 1990-04-19 1993-01-19 Inomet, Inc. Blood constituent measurement
US20030144581A1 (en) * 1999-02-12 2003-07-31 Cygnus, Inc. Devices and methods for frequent measurement of an analyte present in a biological system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
AKIMOTO, M. et al. Development of the pulsed direct current iontophoresis and its clinical application. PIERS 2006 - Progress in Electromagnetics Research Symposium, Proceedings - Cambridge (MA, USA), 2006, Vo. 2, No. 2, páginas 157 - 162, <doi:10.2529/PIERS051008021701> <ht tp://w ww.piers.org/piersonline/piers.php?volume=2&number=2&year=2006> *

Also Published As

Publication number Publication date
ES2575234B1 (es) 2017-04-05

Similar Documents

Publication Publication Date Title
EP2778752A3 (en) Method and device for monitoring and treatment of seasonal affective disorder
ES2637417T3 (es) Método para determinar la concentración de glucosa en sangre humana
SA517390218B1 (ar) جهاز وطرق لتحديد النسيج التالف باستخدام قياسات الرطوبة تحت الجلد
CY1118616T1 (el) Λιξισενατιδη ως προσθετη θεραπεια σε βασικη ινσουλινη σε διαβητη τυπου 2
EA201590715A1 (ru) Производные эксендина-4 как двойные агонисты glp1/глюкагона
EP2522984A3 (en) Method and apparatus for post-sequestration monitoring and management of carbon dioxide
EA202092386A1 (ru) Конструкции на основе фактора дифференцировки и роста 15 (gdf15)
MX362190B (es) Agonistas duales de glp1/gip o trigonales de glp1/gip/glucagon.
MX2016006252A (es) Tratamiento o prevencion de afecciones pulmonares con monoxido de carbono.
CY1117603T1 (el) Η λιξισενατιδη ως προσθετο στη μετφορμινη στην θεραπευτικη αγωγη του διαβητη τυπου 2
EA201700123A1 (ru) Способ прогнозирования варианта лекарственного препарата для лечения депрессии
WO2012149485A3 (en) Apparatus and methods for non-invasively measuring physiologic parameters of one or more subjects
WO2016005586A3 (en) Titration of basal insulin with two modes
MX2015015907A (es) Metodo no invasivo objetivo para cuantificar el grado de comezon mediante el uso de mediciones psicofisiologicas.
HUE067607T2 (hu) Folyamatos vércukormérõ készülék
MX347372B (es) Uso de metformina en combinacion con un activador de glucoquinasa y composiciones que comprenden metformina y un activador de glucoquinasa.
PH12017501290A1 (en) Treatment of pediatric type 2 diabetes mellitus patients with lixisenatide
MX2016009102A (es) Composiciones de enolasa 1 (eno1) y sus usos.
EA201690537A1 (ru) Способы и средства для введения контрастной среды
EA201591123A1 (ru) Комбинации агониста glp1r и метформина, а также способ их применения при лечении диабета 2 типа и прочих расстройств
ES2575234A1 (es) Equipo de suministro de insulina no invasivo
ZA202108217B (en) Lipid-based nanoparticles and use of same in optimized insulin dosing regimens
MX2020007661A (es) Un bioensayo para la detección no invasiva del uso de drogas y afecciones fisiológicas.
MX2020007662A (es) Aparato y método para la detección no invasiva del uso de y deterioro por tetrahidrocanabinol.
Rizzo et al. Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012; 35: 2076–2082

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2575234

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20170405

FD2A Announcement of lapse in spain

Effective date: 20211004